A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS

Jonathan S. Katz, Jeffrey D. Rothstein, Merit E. Cudkowicz, Angela Genge, Björn Oskarsson, Avis B. Hains, Chen Chen, Joshua Galanter, Braydon L. Burgess, William Cho, Geoffrey A. Kerchner, Felix L. Yeh, Arundhati Sengupta Ghosh, Sravanthi Cheeti, Logan Brooks, Lee Honigberg, Jessica A. Couch, Michael E. Rothenberg, Flavia Brunstein, Khema R. SharmaLeonard van den Berg, James D. Berry, Jonathan D. Glass

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS'. Together they form a unique fingerprint.

Medicine & Life Sciences